Acrx stock forecast.

May 9, 2023 · ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ... 1.49%. $75.35M. Cara Therapeutics Inc. 13.45%. $73M. ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.6.51M. ZOMT. 106.30. -1.80%. 108.56M. View the real-time AcelRx (NASDAQ ACRX) share price and assess historical data, charts, technical analysis and the share chat forum.AcelRx Pharmaceuticals is forecast to grow earnings and revenue by 11.4% and 63.5% per annum respectively while EPS is expected to grow by 33.4% per annum.Nov 22, 2023 · ACRX has an Altman Z-Score of -27.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for AcelRx Pharmaceuticals, Inc. (ACRX) stock, including valuation metrics, financial numbers, share information and more.

ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

AcelRx Pharma Announces 5.34M Share Private Placement at $1.36/sh. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use... Investing.com.Dec 31, 2021 · ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.

Find real-time VRNA - Verona Pharma PLC stock quotes, company profile, news and forecasts from CNN Business.Forecast . Price target. 4.63 0.00 0.00%. The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to ACRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreACRX Stock 12 Months Forecast. $5.00. (624.74% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Acelrx in the last 3 months. The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 624.74% change from the last price of $0.69. Find the latest AcelRx Pharmaceuticals, Inc. ACRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ...

AcelRx Pharmaceuticals, Inc. 05 Apr, 2023, 08:30 ET. In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant. AcelRx announces full ...

Find real-time SPRO - Spero Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Get the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ... AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Welcome to the AcelRx third quarter 2023 financial results conference call.Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 31.00, with a high estimate of 31.26 and a low estimate of 19.00. The median ...222.96%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -4.11M. 12.66%. Get the latest Achieve Life Sciences Inc ...CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its quarterly earnings results on Thursday, November, 11th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.22. The company had revenue of $3.83 million for the quarter.AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Share $0.69 After Hours: $0.75 (9.34%) +0.064 Closed: Nov 29, 4:02:05 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Trevena Inc $0.58 TRVN1.05% DURECT Corp $0.65 DRRX4.33% Pieris...Future criteria checks 1/6. Acerinox is forecast to grow earnings and revenue by 14% and 1.9% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 11.2% in 3 years.Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The forecasts range from a low of $4.25 to a high of $5.00. The average price target represents an increase of 571.01% from the last closing price of $0.69. …Nov 17, 2014 · Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Corbus Pharmaceuticals Holdings Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. Here are three reasons Aurora Cannabis stock may finally be a buy. Image source: Getty Images. 1. Cost-cutting and restructuring. Aurora Cannabis has been implementing a comprehensive plan to ...Find real-time CTMX - CytomX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

SmartAssetPaid Partner. Find real-time CTMX - CytomX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.AcelRx Pharmaceuticals, Inc. 05 Apr, 2023, 08:30 ET. In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant. AcelRx announces full ...

Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.What's ACRX's stock forecast? By Mohit Oberoi, CFA Jan. 14 2021, Published 8:19 a.m. ET Source: Unsplash AcelRx (ACRX) stock made a new 52-week …Stock Price Forecast The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ...Stock Price Forecast The 1 analysts offering 12-month price forecasts for Iterum Therapeutics PLC have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. Find the latest Revelation Biosciences, Inc. (REVB) stock quote, history, news and other vital information to help you with your stock trading and investing.The 2 analysts offering 1 year price forecasts for AcelRx Pharmaceuticals, Inc. have a max estimate of 5.0000 and a min estimate of 4.2500. Analyst rating Based on 2 analysts …ACRX Stock 12 Months Forecast. $5.00. (624.74% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Acelrx in the last 3 months. The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 624.74% change from the last price of $0.69.ACR's primary purpose was subsequently changed to that of an investment holding company with oil exploration as secondary purpose. On October 10, 1996, ACR completed its reorganization through a series of stock swaps, and as a result, some of the AG's established businesses became majority- or minority-owned subsidiaries of ACR.Analyst Forecast. According to 7 analysts, the average rating for APLD stock is "Strong Buy." The 12-month stock price forecast is $14.21, which is an increase of 204.28% from the latest price.

AcelRx Pharmaceuticals ( NASDAQ: ACRX) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.80 and the consensus Revenue ...

Find the latest FormFactor, Inc. (FORM) stock quote, history, news and other vital information to help you with your stock trading and investing.

Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67. Find real-time INPX - Inpixon stock quotes, company profile, news and forecasts from CNN Business.Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67. AcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. 1.ACRX Stock USD 1.76 0.08 4.35% AcelRx Pharmaceuticals stock price prediction is an act of determining the future value of AcelRx Pharmaceuticals shares using few different conventional methods such as EPS estimation , analyst consensus, or …377.43. -0.11%. 9.38M. View today's AcelRx Pharmaceuticals Inc stock price and latest ACRX news and analysis. Create real-time notifications to follow any changes in the live stock price.Acelrx Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "ACRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Acelrx Pharmaceuticals Inc (ACRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Currently 8 wall-street analysts regularly analyze the financials of Acelrx Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Acelrx Pharmaceuticals, Inc. (ACRX) have a share price target of $4.63.The image below, which you can click on for greater detail, shows that at December 2021 Achieve Life Sciences had debt of US$14.9m, up from none in one year. However, it does have US$43.0m in cash ...

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Acelrx Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock Price Forecast The 2 analysts offering 12-month price forecasts for Vistagen Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00.Instagram:https://instagram. how much is a half dollar coinmerrill lynch merrill edgechart coinbasebmgkx ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now. schd dividend payoutchevron stock price history If you’re looking for penny stocks to buy right now, analysts may be a point of focus.... carvana atock Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...According to our price prediction algorithm,AcelRx Pharmaceuticals, Inc. (ACRX) price will be around $0.84 in the next 2 weeks.This means it will decrease by -11.41% from the last closing price. This prediction may vary from other …